Business in brief
Paratek Pharmaceuticals Inc. said it has closed the first round of a $40 million private financing. The Boston company is engaged in the discovery and commercialization of new therapeutics that treat serious diseases, with a focus on the growing worldwide problem of antibiotic resistance. The funds will be used primarily to advance programs to develop broad spectrum antibiotics, ... (Full article: 699 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
